Document is current
Any future updates will be listed below
-
Authors
Ramji, Niranjan
Xie, Sancai
Bunger, Ashley
Trenner, Rachel
Ye, Hao
Farmer, Teresa
Reichling, Tim
Ashe, Julie
Milleman, Kimberly
Milleman, Jeffery
Klukowska, Malgorzata
- License Information
-
More Information
Article History
Received: 6 May 2024
Accepted: 20 August 2024
First Online: 30 August 2024
Declarations
:
: The protocol was reviewed and approved by the U.S Investigational Review Board, Inc. in Miami, Florida (U.S.IRB2022SRI/03) and registered on clinicaltrials.gov (NCT05326373-13/04/2022). The study was conducted from April 11, 2022 to June 17, 2022 in accordance with the International Conference on Harmonization’s Good Clinical Practice guidelines and in compliance with applicable sections of the US Federal Regulations governing informed consent (21 CFR 50) and IRBs (21 CFR 56). All participants provided written, informed consent.
: Not applicable.
: JM and KM have no competing interest to declare. All other authors are employees of The Procter & Gamble Company, the study sponsor.
